Improved phenotype-based definition for identifying carbapenemase producers among carbapenem - Resistant enterobacteriaceae

Emerging Infectious Diseases

Volumn 21, Issue 9, 2015, Pages 1611-1616

  Chea, Nora ^a   Bulens, Sandra N ^a   Kongphet Tran, Thiphasone ^a   Lynfield, Ruth ^b   Shaw, Kristin M ^b   Vagnone, Paula Snippes ^b   Kainer, Marion A ^c   Muleta, Daniel B ^c   Wilson, Lucy ^d   Vaeth, Elisabeth ^d   Dumyati, Ghinwa ^d,e   Concannon, Cathleen ^d,e   Phipps, Erin C ^f   Culbreath, Karissa ^f   Janelle, Sarah J ^g   Bamberg, Wendy M ^g   Guh, Alice Y ^a   Limbago, Brandi ^a   Kallen, Alexander J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

^c TENNESSEE DEPARTMENT OF HEALTH   (United States)

^d University of Rochester Medical Center ^*  (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f UNIVERSITY OF NEW MEXICO   (United States)

^g Air Pollution Control Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; CEFEPIME; CEPHALOSPORIN; DORIPENEM; ERTAPENEM; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; DISEASE TRANSMISSION; ENTEROBACTER; ESCHERICHIA COLI; KLEBSIELLA; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; ANTIBIOTIC RESISTANCE; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; DIAGNOSTIC TEST; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; EVALUATION STUDY; GENETICS; HEALTH SURVEY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; STANDARDS; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; DIAGNOSTIC TESTS, ROUTINE; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; PHENOTYPE; PUBLIC HEALTH SURVEILLANCE; UNITED STATES;

EID: 84939535611     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2109.150198     Document Type: Article

References (16)

1. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:155-64. http://dx.doi.org/10.1086/524891
2. Smolinski MS, Hamburg MA, Lederberg J. Microbial threats to health: emergence, detection, and response. Washington: The National Academies Press; 2003.
3. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53:60-7. http://dx.doi.org/10.1093/cid/cir202
4. Centers for Disease Control and Prevention. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep. 2013;62:165-70.
5. Lee CS, Vasoo S, Hu F, Patel R, Doia Y. Klebsiella pneumoniae ST147 coproducing NDM-7 carbapenemase and RmtF 16S rRNA methyltransferase in Minnesota. J Clin Microbiol. 2014;52:4109-10. http://dx.doi.org/10.1128/JCM.01404-14
6. Mathers AJ, Hazen KC, Carroll J, Yeh AJ, Cox HL, Bonomo RA, et al. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world. J Clin Microbiol. 2013;51:680-3. http://dx.doi.org/10.1128/JCM.02580-12
7. Centers for Disease Control and Prevention. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep. 2009;58:256-60.
8. Epstein L, Hunter JC, Arwady MA, Tsai V, Stein L, Gribogiannis M, et al. New Delhi metallo-β-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA. 2014;312:1447-55. http://dx.doi.org/ 10.1001/jama.2014.12720
9. Epson EE, Pisney LM, Wendt JM, MacCannell DR, Janelle SJ, Kitchel B, et al. Carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-β-lactamase at an acute care hospital, Colorado, 2012. Infect Control Hosp Epidemiol. 2014;35:390-7. http://dx.doi.org/10.1086/675607
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-fourth informational supplement. M100-S24. Wayne (PA): The Institute; 2014.
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement. M100-S23. Wayne (PA): The Institute; 2013.
12. Rasheed JK, Kitchel B, Zhu W, Anderson KF, Clark NC, Ferraro MJ, et al. New Delhi metallo-β-lactamase-producing Enterobacteriaceae, United States. Emerg Infect Dis. 2013;19:870-8. http://dx.doi.org/10.3201/eid1906.121515
13. Nordmann P, Poirel L. Strategies for identification of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2013;68:487-9. http://dx.doi.org/10.1093/jac/dks426
14. Tijet N, Boyd D, Patel SN, Mulvey MR, Melano RG. Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2013;57:4578-80. http://dx.doi.org/10.1128/AAC.00878-13
15. Voulgari E, Poulou A, Koumaki V, Tsakris A. Carbapenemase-producing Enterobacteriaceae: now that the storm is finally here, how will timely detection help us fight back? Future Microbiol. 2013;8:27-39. http://dx.doi.org/10.2217/fmb.12.130
16. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18:1503-7. http://dx.doi.org/10.3201/eid1809.120355